Evidence map›Paper›PMID 34824209›Full record

ArticleNature communications2021

Plasma virome and the risk of blood-borne infection in persons with substance use disorder.

Abraham J Kandathil, Andrea L Cox, Kimberly Page, David Mohr, Roham Razaghi, Khalil G Ghanem, Susan A Tuddenham, Yu-Hsiang Hsieh, Jennifer L Evans, Kelly E Coller and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Oral virome in health and disease.Journal of the American Dental Association (1939) · 2026
    Review
  2. Article
  3. Article
  4. The Blood Virome: A new frontier in biomedical science.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Abraham J KandathilDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-9038-134X
Andrea L CoxDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Kimberly PageDepartment of Internal Medicine, University of New Mexico, Albuquerque, NM, USA.
David MohrDepartment of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Roham RazaghiDepartment of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Khalil G GhanemDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Susan A TuddenhamDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Yu-Hsiang HsiehDepartment of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Jennifer L EvansDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA.
Kelly E CollerCore Diagnostics, Abbott Laboratories, Abbott Park, IL, USA.
Winston TimpDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0003-2083-6027
David D CelentanoDepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Stuart C RayDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-1051-7260
David L ThomasDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. dthomas@jhmi.edu.
Johns Hopkins University · USAbbott Fund · USUniversity of California, San Francisco · USUniversity of New Mexico · US

Funding

The development and pre-clinical assessment of novel HCV vaccines to generate T and B cell immunityU19AI159822 · NIAID · JOHNS HOPKINS UNIVERSITY · PI COX, ANDREA L · 2021 to 2025
$14.4M
Acute Hepatitis C Infection in Young InjectorsR01DA016017 · NIDA · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI PAGE, KIMBERLY · 2002 to 2018
$14.0M
The Impact of HCV Treatment in HIV/HCV coinfected and HCV monoinfected Incarcerated Persons on HCV EliminationR01DA013806 · NIDA · JOHNS HOPKINS UNIVERSITY · PI IRVIN, RISHA, THOMAS, DAVID L · 2000 to 2024
$8.7M
HIV HCV Coinfection Antiviral Therapy and FibrosisR37DA013806 · NIDA · JOHNS HOPKINS UNIVERSITY · PI THOMAS, DAVID L · 2010 to 2019
$7.0M
Characterization of plasma virome in people who inject drugs to identify early transmission networks of HIV and other bloodborne infectionsR21DA053145 · NIDA · JOHNS HOPKINS UNIVERSITY · PI KANDATHIL, ABRAHAM · 2021 to 2022
$450k
NIAID NIH HHS U19 AI159822NIDA NIH HHS R01 DA013806NIDA NIH HHS R01 DA016017NIDA NIH HHS R21 DA053145NIDA NIH HHS R37 DA013806
6 · The paper itself

Abstract

There is an urgent need for innovative methods to reduce transmission of bloodborne pathogens like HIV and HCV among people who inject drugs (PWID). We investigate if PWID who acquire non-pathogenic bloodborne viruses like anelloviruses and pegiviruses might be at greater risk of acquiring a bloodborne pathogen. PWID who later acquire HCV accumulate more non-pathogenic viruses in plasma than matched controls who do not acquire HCV infection. Additionally, phylogenetic analysis of those non-pathogenic virus sequences reveals drug use networks. Here we find first in Baltimore and confirm in San Francisco that the accumulation of non-pathogenic viruses in PWID is a harbinger for subsequent acquisition of pathogenic viruses, knowledge that may guide the prioritization of the public health resources to combat HIV and HCV.

Indexed as

Blood-Borne InfectionsPlasmaSubstance-Related DisordersViromeAdultAmino Acid SequenceAnelloviridaeBlood-Borne PathogensFemaleHepatitis CHumansKnowledgeMaleMetagenomicsPhylogenyPublic Health

Identifiers

PMID34824209
PMCPMC8617242
OpenAlexW3215063454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.